OncoMed Pharmaceuticals Inc Deferred Offering Costs
OncoMed Pharmaceuticals Inc had Deferred Offering Costs of $300.00 thousand as of 2015-06-30, per its 10-Q filed 2015-08-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2015-08-10
- 2015-06-30: Deferred Offering Costs $300.00K.
- 2012-12-31: Deferred Offering Costs $2.90M.
| Period end | Deferred Offering Costs |
|---|---|
| 2015-06-30 | $300.00K 10-Q · filed 2015-08-10 |
| 2012-12-31 | $2.90M 10-K · filed 2014-03-18 |